[go: up one dir, main page]

NO784229L - Nye organiske forbindelser samt fremgangsmaate for deres fremstilling - Google Patents

Nye organiske forbindelser samt fremgangsmaate for deres fremstilling

Info

Publication number
NO784229L
NO784229L NO784229A NO784229A NO784229L NO 784229 L NO784229 L NO 784229L NO 784229 A NO784229 A NO 784229A NO 784229 A NO784229 A NO 784229A NO 784229 L NO784229 L NO 784229L
Authority
NO
Norway
Prior art keywords
procedures
preparation
organic compounds
new organic
new
Prior art date
Application number
NO784229A
Other languages
English (en)
Other versions
NO148776C (no
NO148776B (no
Inventor
Nicholas S Bodor
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of NO784229L publication Critical patent/NO784229L/no
Publication of NO148776B publication Critical patent/NO148776B/no
Publication of NO148776C publication Critical patent/NO148776C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO784229A 1977-12-16 1978-12-15 Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering NO148776C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (3)

Publication Number Publication Date
NO784229L true NO784229L (no) 1979-06-19
NO148776B NO148776B (no) 1983-09-05
NO148776C NO148776C (no) 1983-12-14

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784229A NO148776C (no) 1977-12-16 1978-12-15 Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering

Country Status (15)

Country Link
JP (1) JPS5498711A (no)
AR (1) AR222478A1 (no)
AT (1) AT366380B (no)
AU (1) AU531835B2 (no)
CA (1) CA1102345A (no)
DE (1) DE2854308A1 (no)
DK (1) DK534178A (no)
ES (1) ES476048A1 (no)
FR (1) FR2422624A1 (no)
GB (1) GB2010270B (no)
IE (1) IE48012B1 (no)
IT (1) IT1101735B (no)
NL (1) NL7812257A (no)
NO (1) NO148776C (no)
SE (1) SE436027B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (de) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim Heterocyclische verbindungen
JPS5993075A (ja) * 1982-11-18 1984-05-29 Shionogi & Co Ltd 1−フタリジル−5−フルオロウラシル誘導体の製造法
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (fr) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Procédé de préparation d'oxalates et d'halogénoglyoxalates alpha- monohalogénés et nouveaux oxalates et halogénoglyoxalates alpha-monohalogénés .
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (es) 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
CA2610708C (en) 2005-06-03 2013-10-08 Acrux Dds Pty Ltd Method and composition for transdermal drug delivery
AP2008004537A0 (en) * 2005-12-30 2008-08-31 Ranbaxy Lab Ltd Muscarinic receptor antagonists
BRPI0819235A2 (pt) 2007-11-02 2017-08-22 Acrux Dds Pty Ltd Sistema de distribuição transdérmica para hormônios e esteróides
JP6621329B2 (ja) * 2012-10-05 2019-12-18 スファエラ ファーマ ピーティーイー リミテッド 新規化合物、それらの合成及びそれらの使用
DE102013013397A1 (de) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen
CN110041264A (zh) * 2019-04-11 2019-07-23 贺州学院 一种金刚烷基咪唑类离子液体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL101555C (no) * 1955-03-19
BE798253A (nl) * 1973-04-16 1973-10-16 Bekaert Sa Nv Zitmeubel
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Also Published As

Publication number Publication date
IE48012B1 (en) 1984-09-05
FR2422624B1 (no) 1983-10-14
DE2854308A1 (de) 1979-06-21
FR2422624A1 (fr) 1979-11-09
AT366380B (de) 1982-04-13
IT7830735A0 (it) 1978-12-12
SE436027B (sv) 1984-11-05
ES476048A1 (es) 1979-11-01
IT1101735B (it) 1985-10-07
NL7812257A (nl) 1979-06-19
ATA901478A (de) 1981-08-15
AU531835B2 (en) 1983-09-08
JPS5498711A (en) 1979-08-03
DK534178A (da) 1979-06-17
SE7812911L (sv) 1979-06-17
GB2010270A (en) 1979-06-27
NO148776C (no) 1983-12-14
CA1102345A (en) 1981-06-02
NO148776B (no) 1983-09-05
GB2010270B (en) 1982-10-20
AU4264678A (en) 1979-06-21
AR222478A1 (es) 1981-05-29
IE782499L (en) 1979-06-16

Similar Documents

Publication Publication Date Title
SE7805770L (sv) Anordning for instellning av foremal
FI781043A7 (fi) Styranordning foer en projektil av rakettyp samt en projektil foersedd med en dylik anordning
SE7808555L (sv) Skyddsgrind
NO784229L (no) Nye organiske forbindelser samt fremgangsmaate for deres fremstilling
FI780084A7 (fi) Sondskydd
DK488078A (da) Quinazolin-derivater fremgangsmaade til deres fremstilling samt deres anvendelse
NO780071L (no) Nye oksazolidinderivater.
FI782444A7 (fi) Baerhandtag foer behaollare
NO784281L (no) Fremgangsmaate til fremstilling av nye 2alfa-cyano-3-okso-steroider
NO783958L (no) Fremgangsmaate for fremstilling av nye indolokinolizidiner
DK203378A (da) Azolylether-derivater fremgangsmaade til deres fremstilling samt deres anvendelse som fungicider
DK37278A (da) Meta-sulfonamido-benzamid-derivater samt fremgangsmaade til fremstilling deraf
NO783323L (no) Nye fenyl-isotiocyanat-derivater
DE2805500B2 (de) Inkubator
DK149651C (da) Organiske pigmentpraeparater
FI780602A7 (fi) Foerfarande foer nedsaettning av halogenvaetehalten i roekgaser fraon avfallsfoerbraenningsugnar samt anordning foer utfoerande av foerfarandet
NO831790L (no) Nye pyrido-indol-derivater.
FI782155A7 (fi) Foerbaettringar i organiska foereningar
DK391678A (da) Nitrogen-heterocycliske forbindelser fremgangsmaade til deres fremstilling samt deres anvendelse
FI780028A7 (fi) Piperidinderivater
AR221217A1 (es) Procedimiento para recuperar valores de titanio
DK564778A (da) Azolylalkyl-pyridinyl-ethere fremgangsmaader til deres fremstilling samt deres anvendelse som fungicider
DK562778A (da) 1-halogen-1-propin-3-oler fremgansmaade til deres fremstilling samt deres anvendelse som fungicider
NO784128L (no) Nye tetrapeptider og fremgangsmaate til deres fremstilling
DK206377A (da) Substituerede pyrazolopyriminer fremgangsmade til deres fremstilling samt deres anvendelse